Extent of coronary atherosclerosis and homocysteine affect endothelial markers

Angiology

Volumn 52, Issue 9, 2001, Pages 589-596

  Yildirir, Aylin ^a   Tokgozoglu, S Lale ^a   Kabakci, Giray ^a   Ovunc, Kenan ^a   Aksoyek, Serdar ^a   Oto, Ali ^a   Ozmen, Ferhan ^a   Kes, Sirri ^a   Haznedaroglu, Ibrahim ^b   Kirazli, Serafettin ^b   Sinici, Incilay ^c  

^a Departments of Cardiology   (United States)

^b Departments of Hematology   (United States)

^c Medical Biochemistry   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CELL MARKER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HOMOCYSTEINE; TROPONIN I; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RISK FACTOR; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ARTERIOSCLEROSIS; CORONARY DISEASE; E-SELECTIN; ENDOTHELIUM, VASCULAR; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0034821227     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970105200902     Document Type: Article

References (32)

1. The pathogenesis of atherosclerosis: A perspective for the 1990s
2. Studies of hypercholesterolemia in the nonhuman primate, I: Change that leads to fatty streak formation
3. The role of monocytes in atherosclerosis, I; transition of blood-borne monocytes into foam cells in fatty lesions
4. The pathogenesis of atherosclerosis: Atherogenesis and inflammation
5. Homocysteine and coronary artery disease
6. Association of Helicobacter pylori and chlamydia pneumonia infections with coronary artery disease and cardiovascular risk factors
7. New indices of ischaemic heart disease and aging: Studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischaemic heart disease
8. Elevated serum concentrations of soluble adhesion molecules in coronary artery disease and acute myocardial infarction
9. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin
10. Homocysteine and vascular disease
11. A more meaningful scoring system for determining the severity of coronary heart disease
12. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis
13. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium
14. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques: Implications for the mode of progression of advanced coronary atherosclerosis
15. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis
16. Circulating intercellular adhesion molecule-1 (ICAM1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies
17. Circulating adhesion molecules in disease
18. Increased levels of the soluble adhesion molecule E-selectin in essential hypertension
19. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1
20. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis
21. Circulating endothelial cell/leukocyte adhesion molecules in ischaemic heart disease
22. Levels of soluble cell adhesion molecules in patients with dyslipidemia
23. Elevated serum intercellular adhesion molecule-1 and vascular adhesion molecule-1 among patients with stable angina pectoris who suffer cardiovascular death or non-fatal myocardial infarction
24. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina
25. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
26. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European concerted action on thrombosis, and disabilities angina pectoris study group
27. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease
28. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
29. Inflammation, provastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels
30. Elevation of C-reactive protein in 'active' coronary artery disease
31. Measurement of serum C-reactive protein concentrations in myocardial ischemia and infarction
32. Methylene tetrahydrofolate reductase genotype and the risk and extent of coronary artery disease in a population with low plasma folate